XML 36 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Composition of Certain Financial Statement Captions (Tables)
6 Months Ended
Jun. 30, 2016
Compositions of Certain Financial Statement Captions [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands)
June 30,
2016
 
December 31,
2015
Accounts receivable, net
 
 
 
Accounts receivable
$
262,145

 
$
219,043

Less: allowance for doubtful accounts
(48,773
)
 
(25,168
)
 
$
213,372

 
$
193,875

Inventories, net
 
 
 
Consumable supplies
$
22,825

 
$
22,265

Finished products
13,944

 
13,404

Work in-process
1,137

 
1,215

Raw materials
5,453

 
3,848

Less: inventory reserve
(1,313
)
 
(1,051
)
 
$
42,046

 
$
39,681

Other current assets and prepaid expenses
 
 
 
Taxes recoverable
52,588

 
3,076

Other receivables
13,464

 
11,946

Prepaid supplies
9,534

 
8,773

Prepaid insurance
2,144

 
2,206

Other
776

 
903

 
$
78,506

 
$
26,904

Intangible assets, net:
 
 
 
Customer relationships
$
450,792

 
$
449,972

Technologies
339,307

 
151,709

Trade names
50,469

 
50,416

Licenses
23,509

 
23,432

Covenants not to compete
16,362

 
8,612

Product registrations
7,836

 
7,512

Other
4,394

 
5,600

Less: accumulated amortization
(88,224
)
 
(59,101
)
 
$
804,445

 
$
638,152

Accrued expenses:
 
 
 
Deferred revenue
$
73,112

 
$
70,246

Employee benefits
37,121

 
29,751

Contingent consideration
30,294

 
22,164

Taxes payable
10,954

 
7,605

Capital leases short-term
5,069

 
5,373

Clinical trials
10,051

 
2,505

Milestone payment
4,966

 
5,000

Professional fees
1,967

 
1,506

Other
36,314

 
23,749

 
$
209,848

 
$
167,899

 
 
 
 
(In thousands)
June 30,
2016
 
December 31,
2015
Other long-term liabilities:
 
 
 
Deferred revenue
$
125,348

 
$
162,634

Line of credit
38,135

 
72,107

Contingent consideration
36,340

 
32,258

Mortgages and other debts payable
1,807

 
2,523

Capital leases long-term
8,500

 
9,285

Other
14,186

 
13,663

 
$
224,316

 
$
292,470

Changes in Goodwill
The following table reflects the changes in Goodwill during the six months ended June 30, 2016.
 
2016
(In thousands)
Balance at January 1st
 
Purchase accounting adjustments
 
Foreign exchange
 
Balance at June 30th
Pharmaceuticals
 
 
 
 
 
 
 
CURNA
$
4,827

 
$

 
$

 
$
4,827

EirGen
81,139

 

 
1,573

 
82,712

FineTech
11,698

 

 

 
11,698

OPKO Chile
4,517

 

 
309

 
4,826

OPKO Biologics
139,784

 

 

 
139,784

OPKO Health Europe
7,191

 

 
130

 
7,321

OPKO Renal
2,069

 

 

 
2,069

 
 
 
 
 
 
 
 
Diagnostics
 
 
 
 
 
 
 
Bio-Reference
441,158

 
(54,300
)
 

 
386,858

OPKO Diagnostics
17,977

 

 

 
17,977

OPKO Lab
32,988

 

 

 
32,988

 
$
743,348

 
$
(54,300
)
 
$
2,012

 
$
691,060